Corcept Therapeutics
CORT
#2425
Rank
C$10.61 B
Marketcap
C$96.96
Share price
-3.25%
Change (1 day)
-7.69%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): C$2.13

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is C$2.15. In 2025 the company made an earnings per share (EPS) of C$1.34 a decrease over its 2024 EPS that were of C$1.93.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.1358.55%
2025C$1.34-30.37%
2024C$1.93
2022C$1.36-2.06%
2021C$1.395.43%
2020C$1.3210.84%
2019C$1.1927.69%
2018C$0.93-42.48%
2017C$1.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.55 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.51 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.18 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.46 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C-$0.19-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02861-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA